NCT00967785
- Conditions
- Agammaglobulinemia, Agranulocytosis, Blood Protein Disorders, +21 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Explore clinical trials studying Agammaglobulinemia. Study availability and eligibility vary by location and protocol.
NCT00967785
NCT02231879
NCT03961009
NCT00161993
NCT01581593
NCT02508584
NCT03401268
NCT01002755
NCT00115778